ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

In Brief: Contracts For Comparative NMR Imaging studies Awarded To Five Institutions; NCI Staff Honored

June 8, 1984

Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report

July 30, 1999

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

RFA: Long-Term Cancer Survivors

September 12, 1997